More and more patients from different parts of the world become afflicted with cancer, a serious disease caused by abnormal cell growths with the potential to spread to other parts of the body. This disease remains one of the leading causes of mortality and morbidity worldwide with more than eight million related deaths in 2012 alone.
Many patients die from the condition due to lack of access to quality medical care, delayed diagnosis, and the rising cost of healthcare. This gap in the healthcare industry has opened doors to medical tourism where patients travel abroad to take advantage of advanced but affordable treatment that may not be available in their own country.
Patients with malignant lymphoma of extranodal or any solid organ site have the option to travel to Singapore, Thailand, and Malaysia where cancer care is a top specialty. In these countries, comprehensive oncology treatment, ranging from diagnosis to palliative care, is offered at a significantly lower cost than in the United States and United Kingdom. With this option, patients get easy access to internationally qualified oncologists who can deliver the highest level of care that meets international standards. Many cancer specialists practicing in Singapore, Thailand, and Malaysia are trained at prestigious cancer centres in Western countries such as Memorial Sloan-Kettering Cancer Centre in New York (USA), Cancer Centre London (UK), and German Cancer Research Centre (Germany), among others. Such training empowers oncologists in Southeast Asia to improve their skills and learn about breakthrough methods, best medical and surgical practices, and cutting-edge technologies.
Aside from having a number of highly qualified cancer specialists, Singapore, Thailand, and Malaysia also boast a long list of Joint Commission International (JCI)-accredited hospitals with dedicated oncology centres. Such hospitals are fully equipped with sophisticated technologies and advanced, modern facilities allowing oncologists to effectively address both common and complex cases of extranodal lymphoma.